Stock GETI B GETINGE AB
Add to a list
To use this feature you must be a member
Log inSign up

Financials Getinge AB

Equities

GETI B

SE0000202624

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm
Other stock markets
 11:29:59 2024-05-31 am EDT 		5-day change 1st Jan Change
187 SEK -1.01% Intraday chart for Getinge AB -2.09% -16.63%
May. 15 Nordic Shares Moved Upward Wednesday; BioArctic Series B Topped Leaders DJ
May. 15 Getinge Shares Sink After It Limits Sales of Heart Devices DJ

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 47,392 52,322 107,613 58,914 61,092 50,933 - -
Enterprise Value (EV) 1 56,158 56,472 111,222 61,516 69,104 57,336 55,313 52,828
P/E ratio 38.8 x 16.2 x 36.2 x 23.6 x 25.3 x 18.6 x 15.9 x 13.9 x
Yield 0.86% 1.56% 1.01% 1.96% 1.96% 2.54% 2.84% 3.19%
Capitalization / Revenue 1.78 x 1.75 x 3.98 x 2.08 x 1.92 x 1.5 x 1.43 x 1.36 x
EV / Revenue 2.11 x 1.89 x 4.11 x 2.17 x 2.17 x 1.69 x 1.55 x 1.41 x
EV / EBITDA 11.3 x 7.54 x 16.5 x 10.4 x 12.4 x 8.88 x 7.7 x 6.73 x
EV / FCF 21.5 x 9.18 x 19.8 x 32.4 x 43.1 x 17.6 x 15.1 x 12.8 x
FCF Yield 4.65% 10.9% 5.06% 3.08% 2.32% 5.67% 6.62% 7.82%
Price to Book 2.26 x 2.44 x 4.27 x 1.93 x 2.01 x 1.58 x 1.49 x 1.39 x
Nbr of stocks (in thousands) 272,370 272,370 272,370 272,370 272,370 272,370 - -
Reference price 2 174.0 192.1 395.1 216.3 224.3 187.0 187.0 187.0
Announcement Date 1/30/20 1/28/21 1/28/22 2/1/23 2/1/24 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 26,559 29,819 27,049 28,292 31,827 33,945 35,711 37,384
EBITDA 1 4,986 7,487 6,754 5,891 5,574 6,456 7,185 7,845
EBIT 1 2,813 5,261 4,939 4,096 3,653 4,349 4,969 5,550
Operating Margin 10.59% 17.64% 18.26% 14.48% 11.48% 12.81% 13.92% 14.85%
Earnings before Tax (EBT) 1 1,909 4,485 4,188 3,472 3,343 3,834 4,513 5,137
Net income 1 1,222 3,239 2,970 2,491 2,412 2,791 3,249 3,699
Net margin 4.6% 10.86% 10.98% 8.8% 7.58% 8.22% 9.1% 9.89%
EPS 2 4.480 11.89 10.90 9.150 8.860 10.04 11.80 13.43
Free Cash Flow 1 2,612 6,154 5,630 1,897 1,604 3,254 3,661 4,129
FCF margin 9.83% 20.64% 20.81% 6.71% 5.04% 9.59% 10.25% 11.04%
FCF Conversion (EBITDA) 52.39% 82.2% 83.36% 32.2% 28.78% 50.4% 50.96% 52.63%
FCF Conversion (Net income) 213.75% 190% 189.56% 76.15% 66.5% 116.58% 112.68% 111.61%
Dividend per Share 2 1.500 3.000 4.000 4.250 4.400 4.755 5.308 5.965
Announcement Date 1/30/20 1/28/21 1/28/22 2/1/23 2/1/24 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 7,987 6,182 6,670 6,941 8,498 7,141 7,176 7,607 9,903 7,513 7,821 8,176 10,174
EBITDA 1 2,118 1,235 1,350 1,579 1,727 1,380 902 1,525 1,766 1,255 1,304 1,615 2,189
EBIT 1 1,652 797 913 1,121 1,265 921 442 1,047 1,243 784 817.5 1,123 1,692
Operating Margin 20.68% 12.89% 13.69% 16.15% 14.89% 12.9% 6.16% 13.76% 12.55% 10.44% 10.45% 13.73% 16.63%
Earnings before Tax (EBT) 1 1,075 749 867 1,075 781 826 305 1,227 986 638 624 869.2 1,421
Net income 1 771 534 603 798 556 586 214 894 718 459 443.4 621.5 1,016
Net margin 9.65% 8.64% 9.04% 11.5% 6.54% 8.21% 2.98% 11.75% 7.25% 6.11% 5.67% 7.6% 9.99%
EPS 2 2.830 1.960 2.210 2.930 2.040 2.150 0.7900 3.280 2.640 1.690 1.634 2.282 3.730
Dividend per Share 4.000 - - - - - - - - - - - -
Announcement Date 1/28/22 4/26/22 7/19/22 10/19/22 2/1/23 4/26/23 7/18/23 10/23/23 2/1/24 4/22/24 - - -
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 8,766 4,150 3,609 2,602 8,012 6,403 4,380 1,895
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.758 x 0.5543 x 0.5344 x 0.4417 x 1.437 x 0.9917 x 0.6097 x 0.2416 x
Free Cash Flow 1 2,612 6,154 5,630 1,897 1,604 3,254 3,661 4,129
ROE (net income / shareholders' equity) 6.2% 15.1% 12.9% 8.9% 7.8% 9.08% 9.89% 10.6%
ROA (Net income/ Total Assets) 2.77% 7.22% 6.63% 5.16% 4.74% 5.04% 5.69% 6.17%
Assets 1 44,116 44,863 44,785 48,294 50,889 55,375 57,137 59,980
Book Value Per Share 2 77.00 78.90 92.40 112.0 112.0 119.0 126.0 135.0
Cash Flow per Share 2 14.10 26.40 24.10 - 10.90 21.60 18.00 19.60
Capex 1 1,220 1,045 930 1,136 1,353 1,433 1,489 1,549
Capex / Sales 4.59% 3.5% 3.44% 4.02% 4.25% 4.22% 4.17% 4.14%
Announcement Date 1/30/20 1/28/21 1/28/22 2/1/23 2/1/24 - - -
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Getinge AB

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
187 SEK
Average target price
229.2 SEK
Spread / Average Target
+22.58%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Equipment

1st Jan change Capi.
GETINGE AB Stock Getinge AB
-16.63% 4.86B
SHOCKWAVE MEDICAL, INC. Stock Shockwave Medical, Inc.
+75.69% 12.57B
PENUMBRA, INC. Stock Penumbra, Inc.
-24.68% 7.29B
MASIMO CORPORATION Stock Masimo Corporation
+6.22% 6.7B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD. Stock Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
+12.58% 5.38B
APT MEDICAL INC. Stock APT Medical Inc.
+26.90% 4.58B
ASAHI INTECC CO., LTD. Stock Asahi Intecc Co., Ltd.
-21.14% 3.74B
INARI MEDICAL, INC. Stock Inari Medical, Inc.
-22.99% 2.95B
NOVOCURE LIMITED Stock NovoCure Limited
+47.42% 2.4B
SKAN GROUP AG Stock SKAN Group AG
-0.37% 2.02B
Medical Equipment
  1. Stock Market
  2. Equities
  3. GETI B Stock
  4. Financials Getinge AB